Financial Times | Awards & Rankings
The New York Times Dealbook | Press Mentions
Kirkland represents Bristol-Myers Squibb Company in its agreement announced to acquire Amylin Pharmaceuticals for a total transaction value of approximately $7 billion.
The Am Law Daily | Press Mentions
Kirkland advises Bristol-Myers Squibb in a $2.5 billion acquisition deal with Inhibitex, Inc.
Kirkland & Ellis LLP | Press Releases
Reuters News | Press Mentions
Kirkland represented Bristol-Myers Squibb Co. in its acquisition of ZymoGenetics Inc in a deal valued at $885 million.